Share This

Worthing-based Rayner, a global innovator in cataract and refractive surgery solutions and the only UK manufacturer of intraocular lenses (IOLs), today announced that AEON, its surgery-focused premium eye drops, are now available in Boots Opticians, with more than 500 branches across the UK.

In the UK, there are over 340,000 new eye-surgery patients every year1 of which over 75% will suffer from dry eye disease2: a condition that alters the thickness and quality of the tear film, shifting the refractive power of the cornea by up to 2 dioptres and seriously affecting visual quality.3,4 AEON eye drops are the only eye drops designed for relief of dry eye both before and after eye surgery.

Two AEON products are now available to purchase from Boots Opticians:

  • AEON Protect Plus is designed to improve patient outcomes before and after eye surgery. These eye drops offer longer lasting lubrication with 0.3% cross-linked sodium hyaluronate, for the relief of moderate to severe dry eye.
  • AEON Protect is designed to provide relief for mild to moderate dry eye. These eye drops contain 0.3% sodium hyaluronate with PEG 400 and are a cost-effective alternative to AEON Protect Plus.

Rayner CEO, Tim Clover, said of the announcement “With AEON now being available on the high street shelves of a chain as big as Boots Opticians, this significantly increases our ability to help patients achieve their best possible outcomes from eye surgery.”

Commenting on the launch, Boots Opticians’ Zyra Ahmed, Lenses and Accessories Buyer said: “We are thrilled that AEON eye drops are now available in our stores nationwide. AEON offers our customers who are referred for eye surgery a solution to relieve dry eye, as well as a great option for those with general dry eye.”

To learn more about AEON eye drops, visit


1. 650,000 estimated cataract procedures in UK in 2021: Market Scope, 2021 IOL Market Report. Over 15,000 laser surgery procedures
2. EuroTimes Supplement February 2019: ‘Diagnosing and Treating Ocular Surface Disease in Surgical Patients’.
3. EuroTimes Supplement February 2018: ‘Ocular Surface Disease’.
4. Tu E.Cornea Day, ASCRS 2011.

Share This